Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Quoin PharmaceuticalsSTU:2EB0 19 Quick Ratio is 2.87 as of Mar. 2026, which is 5% below its 10-year median of 3.02. GuruFocus rates STU:2EB0 with a GF Score™ of 19/100. The stock has 1 warning sign investors should review. Among 1,411 Biotechnology companies, Quoin Pharmaceuticals ranks worse than 56.63% on this metric.
Quoin Pharmaceuticals has a quick ratio of 2.87. It generally indicates good short-term financial strength.
The historical rank and industry rank for Quoin Pharmaceuticals's Quick Ratio or its related term are showing as below:
STU:2EB0'
s Quick Ratio Range Over the Past 10 Years
Min: 0.06 Med: 3.02 Max: 4.35
Current: 2.87
During the past 7 years, Quoin Pharmaceuticals's highest Quick Ratio was 4.35. The lowest was 0.06. And the median was 3.02.
STU:2EB0's Quick Ratio is ranked worse than 56.63% of 1411
companies
in the Biotechnology industry
Industry Median: 3.59
vs STU:2EB0: 2.87
Quoin Pharmaceuticals (STU:2EB0) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Quoin Pharmaceuticals Quick Ratio Related Terms
Quoin Pharmaceuticals Quick Ratio Historical Data
* Premium members only.
The historical data trend for Quoin Pharmaceuticals's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:2EB0 vs RVPH, AIM, BRTX: Quick Ratio Comparison
For the Biotechnology subindustry, Quoin Pharmaceuticals's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Quoin Pharmaceuticals Quick Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Quoin Pharmaceuticals's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Quoin Pharmaceuticals's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Quoin Pharmaceuticals's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Quoin Pharmaceuticals (STU:2EB0) has a Quick Ratio of 2.87 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Quoin Pharmaceuticals and its competitors. This is near median its historical median of 3.02. Over the past decade, Quoin Pharmaceuticals' Quick Ratio has ranged from 0.06 to 4.35. According to the industry distribution chart, Quoin Pharmaceuticals ranks #799 out of 1411 companies in the Biotechnology industry, placing it in the top 56.6%.
Is Quoin Pharmaceuticals' Quick Ratio too high?
Quoin Pharmaceuticals' current Quick Ratio of 2.87 is near median its 10-year median of 3.02. Over the past 10 years, this metric has ranged from a low of 0.06 to a high of 4.35. The Biotechnology industry median Quick Ratio is 3.59. Quoin Pharmaceuticals' value of 2.87 is 20.1% below this industry median. Based on the distribution chart, Quoin Pharmaceuticals ranks #799 out of 1411 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Quoin Pharmaceuticals has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Quoin Pharmaceuticals' Quick Ratio compare to RVPH and AIM?
According to the Biotechnology industry distribution chart, Quoin Pharmaceuticals ranks #799 out of 1411 companies for Quick Ratio. This places Quoin Pharmaceuticals in the lower half of its industry. The industry median Quick Ratio is 3.59. Quoin Pharmaceuticals' value of 2.87 is 20.1% below this benchmark. Historically, Quoin Pharmaceuticals' own Quick Ratio has ranged from 0.06 to 4.35 over the past decade. While the company's 10-year median is 3.02 vs. the industry median of 3.59, Quoin Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.59, based on 1,411 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Quoin Pharmaceuticals's current Quick Ratio of 2.87 is 20.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Quoin Pharmaceuticals and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Quoin Pharmaceuticals's current Quick Ratio is 2.87, which is near median its own 10-year median of 3.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quoin Pharmaceuticals stock overvalued right now?
Quoin Pharmaceuticals (STU:2EB0) has a current Quick Ratio of 2.87. The current Quick Ratio is 2.87, which is near median its 10-year median of 3.02 and 20.1% below the Biotechnology industry median of 3.59. Quoin Pharmaceuticals' overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Quoin Pharmaceuticals (STU:2EB0), the current Quick Ratio is 2.87 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
19GF Score
Get the complete analysis for STU:2EB0
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:2EB0 has been successfully added to your 
